SEI INVESTMENTS CO

Position in CTMX — CytomX Therapeutics, Inc.

CIK 350894 OAKS, PA

Position in CTMX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$151,871

-$1,014,894 QoQ

Shares Held

40,499

-83.7% QoQ

Ownership

0.019%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#108

of 178 holders

Holding Since

Sep 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SEI INVESTMENTS CO holds $1,244,853,716 across 210 Biotechnology names. CTMX ranks #169 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	255,073	$236,649,076
2	INSM	INSMED Inc	1,015,870	$108,312,059
3	VRTX	Vertex Pharmaceuticals Inc / Ma	129,981	$64,565,461
4	EXEL	Exelixis, Inc.	1,166,715	$63,480,962
5	ASND	Ascendis Pharma A/S	237,869	$63,444,419
6	INCY	Incyte Corp	498,013	$56,454,752
7	HALO	Halozyme Therapeutics, Inc.	551,116	$43,135,848
8	REGN	Regeneron Pharmaceuticals, Inc.	60,441	$37,687,380

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$151,871	40,499	-83.7%	Shares	Sole	2026-08-14
2026-03-31	$1,166,765	248,248	+100.0%	Shares	Sole	2026-05-13
2025-12-31	$528,768	124,124	-74.6%	Shares	Sole	2026-02-13
2025-03-31	$310,305	487,902	0.0%	Shares	Sole	2025-05-14
2024-12-31	$502,539	487,902	0.0%	Shares	Sole	2025-02-11
2024-09-30	$575,724	487,902	+27.5%	Shares	Sole	2024-11-12
2024-06-30	$466,922	382,723	+493.7%	Shares	Sole	2024-08-13
2021-06-30	$399,125	64,469	-18.2%	Shares	Sole	2021-08-06
2021-03-31	$608,961	78,779	+100.4%	Shares	Sole	2021-05-12
2020-12-31	$257,519	39,316	-63.5%	Shares	Sole	2021-02-08
2020-09-30	$716,683	107,772	—	Shares	Defined	2020-12-04
No filing history on record for this holder in this stock.